Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-046818

Chief Financial Officer acquired 796 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2023-09-01 Grant or award +398 $33.10 $13,174 7,806 D
Mokari Atabak Chief Financial Officer 2023-09-01 Grant or award +398 8,204 D
Loading xslF345X05/ownership.xml…